ProKidney Corp is a late clinical-stage biotech company based in Winston Salem, NC, dedicated to revolutionizing the treatment of Chronic Kidney Disease (CKD) through the development of innovative cell therapy candidates. Their pioneering REACT platform shows promising potential in preserving kidney function and improving the lives of CKD patients.
ProKidney's mission is to address the high unmet need in CKD treatment by focusing on delaying the progression to kidney failure and reducing the reliance on dialysis. Their lead platform programs, including Renal Autologous Cell Therapy (REACT), aim to disrupt the current standard of care and offer new hope for patients suffering from CKD.
Generated from the website